This is an NIH planning grant for organizations preparing cancer prevention and control clinical trials, not a general business funding source. It fits healthcare and biotech organizations doing cancer research; retail, finance, housing, and other businesses outside that space should not bother applying.
| Industry | Estimated fit |
|---|---|
| Healthcare & BiotechMatches your industry (health, clinical) | 85 |
| Agriculture & FarmingLimit: Nothing in this notice points to agriculture & farming | 54 |
| Arts & CultureLimit: Nothing in this notice points to arts & culture | 54 |
| Construction & InfrastructureMatches your industry (infrastructure) | 54 |
| Education & TrainingLimit: Nothing in this notice points to education & training | 54 |
| Energy & Clean TechLimit: Nothing in this notice points to energy & clean tech | 54 |
| Industry | Estimated fit |
|---|---|
| Environment & ConservationLimit: Nothing in this notice points to environment & conservation | 54 |
| Finance & BankingLimit: Nothing in this notice points to finance & banking | 54 |
| Food & BeverageLimit: Nothing in this notice points to food & beverage | 54 |
| Housing & Real EstateLimit: Nothing in this notice points to housing & real estate | 54 |
| ManufacturingLimit: Not clearly about your industry or what you need funding for; check the… | 54 |
| Retail & E-CommerceLimit: Not clearly about your industry or what you need funding for; check the… | 54 |
| Social Services & NonprofitLimit: Nothing in this notice points to social services & nonprofit | 54 |
| Technology & SoftwareLimit: Nothing in this notice points to technology & software | 54 |
| Transportation & LogisticsLimit: Not clearly about your industry or what you need funding for; check the… | 54 |
These are our matcher’s estimates for a typical business in each industry. A real match depends on your size, your state and what you need the money for — check your own fit.
NIH/NCI planning grants (U34) to prepare cancer prevention and control clinical trials—covering prevention, screening, early detection, survivorship and more. Eligible applicants include small and other for-profit businesses, nonprofits, universities, state/local/tribal governments, school districts, housing authorities, faith- and community-based organizations, and some foreign entities.
The purpose of this NOFO is to facilitate well planned clinical trials across the cancer prevention and control spectrum aimed at improving prevention/ interception, cancer-related health behaviors, screening, early detection, healthcare delivery, management of treatment-related symptoms, supportive care, and the long-term outcomes of cancer survivors. Although the scientific literature or preliminary data may provide the rationale for conducting a clinical trial, investigators often lack critical information about the study population, accrual challenges, intervention, outcome/ endpoints, data/statistical challenges or operational risks necessary to finalize the trial protocol completely. These information gaps can result in multiple protocol changes before and after trial start-up, leading to the need for additional time and expenses that may prevent study completion. Further, the suitability and feasibility of new trial designs, which minimize infrastructure and reduce costs may need to be tested in the context of a particular intervention, at-risk group, symptom or venue. Preparatory studies may fill information gaps and address unknowns, improving trial design and knowledge of trial feasibility and thus saving NCI time and money.
Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Topics
Open opportunities funding similar work, from the same funder or in the same place.
NIH BRAIN Initiative grants to develop tools and computational models for high-resolution, synchronous measurement of complex behaviors alongside neural activity in humans and other species. Eligible applicants include…
NIH/NCI K99/R00 career-development award for early-stage postdoctoral researchers (with research or clinical doctorates) transitioning to independent tenure-track faculty positions; requires the candidate to lead an…
NIH/NCI UH3 cooperative agreement to clinically validate established molecular, cellular, or imaging biomarker assays for cancer detection, diagnosis, prognosis, monitoring, or treatment response using specimens from…
NIH/NCI K99/R00 award for early-stage postdoctoral researchers (with research or clinical doctorates) transitioning to independent faculty careers. The applicant is typically the sponsoring institution; eligible…
NIH/NCI cooperative agreement (UH2/UH3) funding validation of molecular, cellular, and imaging biomarker assays for cancer detection, diagnosis, prognosis, monitoring, and treatment response. Open to universities,…
NIH/NCI program funding revision applications to adapt and clinically validate molecular, cellular, or imaging biomarker assays for cancer detection, diagnosis, prognosis, monitoring, and treatment response prediction.…